COVID-19 大流行期间的亚急性（de Quervain）甲状腺炎。
Subacute (De Quervain) thyroiditis during the COVID-19 pandemic.
机构信息
Department of Pathology, A. C. Camargo Cancer Center, Sao Paulo, Brazil.
Fleury Diagnostic Medical Center, Sao Paulo, Brazil.
出版信息
Cancer Cytopathol. 2021 Nov;129(11):844-846. doi: 10.1002/cncy.22449. Epub 2021 May 10.
Abstract
Coronavirus disease 2019 (COVID‐19) is a new disease whose clinical presentation and potential complications are not yet fully understood. One of these possible reported complications is the onset of subacute (De Quervain) thyroiditis (SAT). Here a series of cases of SAT during the COVID‐19 pandemic are reported, and a possible correlation between these 2 entities is extrapolated.
摘要
新型冠状病毒病 2019（COVID-19）是一种新疾病，其临床表现和潜在并发症尚未完全了解。其中一种可能的报告并发症是亚急性（De Quervain）甲状腺炎（SAT）的发作。本文报告了 COVID-19 大流行期间发生的一系列 SAT 病例，并推断了这两种疾病之间可能存在的相关性。
相似文献
1
Subacute (De Quervain) thyroiditis during the COVID-19 pandemic.
Cancer Cytopathol. 2021 Nov;129(11):844-846. doi: 10.1002/cncy.22449. Epub 2021 May 10.
2
Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome.
J Clin Endocrinol Metab. 2021 Aug 18;106(9):2600-2605. doi: 10.1210/clinem/dgab373.
3
Incidence of De Quervain's thyroiditis during the COVID-19 pandemic in an area heavily affected by Sars-CoV-2 infection.
Endocrine. 2021 Nov;74(2):215-218. doi: 10.1007/s12020-021-02841-8. Epub 2021 Aug 7.
4
Subacute thyroiditis after inactive SARS-CoV-2 vaccine.
BMJ Case Rep. 2021 Oct 1;14(10):e244711. doi: 10.1136/bcr-2021-244711.
5
Breast cancer and COVID-19 pandemic in Brazil.
J Surg Oncol. 2020 Nov;122(6):1260-1261. doi: 10.1002/jso.26143. Epub 2020 Aug 5.
6
Subacute De Quervain thyroiditis after SARS-CoV-2 infection.
Endocrinol Diabetes Nutr (Engl Ed). 2021 Dec;68(10):754-755. doi: 10.1016/j.endien.2020.10.010. Epub 2021 Dec 8.
7
Non-toxic goitre: diagnostic role of aspiration cytology, antibodies and serum thyrotrophin.
Clin Endocrinol (Oxf). 1978 Dec;9(6):505-14. doi: 10.1111/j.1365-2265.1978.tb01508.x.
8
Cancer diagnosis in Brazil in the COVID-19 era.
Semin Oncol. 2021 Apr;48(2):156-159. doi: 10.1053/j.seminoncol.2020.12.002. Epub 2021 Jan 7.
9
Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic.
Hormones (Athens). 2021 Mar;20(1):219-221. doi: 10.1007/s42000-020-00230-w. Epub 2020 Jul 16.
10
[SUBACUTE THYROIDITIS AND COVID-19 (REVIEW)].
Georgian Med News. 2021 Feb(311):98-103.
引用本文的文献
1
Subacute thyroiditis as a post-COVID-19 complication: a systematic review.
BMC Infect Dis. 2025 Jul 1;25(1):862. doi: 10.1186/s12879-025-10518-0.
2
Long-Term Impacts of COVID-19 on Thyroid Health: Insights From Clinical Studies.
Cureus. 2024 Oct 14;16(10):e71469. doi: 10.7759/cureus.71469. eCollection 2024 Oct.
3
Subacute Thyroiditis in Active COVID-19 Infection: A Report of Two Cases With a Systematic Review of the Literature.
Cureus. 2024 Jan 20;16(1):e52611. doi: 10.7759/cureus.52611. eCollection 2024 Jan.
4
Thyroid dysfunction in COVID-19.
Nat Rev Endocrinol. 2024 Jun;20(6):336-348. doi: 10.1038/s41574-023-00946-w. Epub 2024 Feb 12.
5
Clinical Aspects in Subacute Thyroiditis: A Real-Life Study on 226 Cases in Greece Amid the COVID-19 Pandemic.
J Clin Med. 2023 Nov 18;12(22):7171. doi: 10.3390/jcm12227171.
6
Subacute thyroiditis following COVID-19: A systematic review.
Front Endocrinol (Lausanne). 2023 Apr 5;14:1126637. doi: 10.3389/fendo.2023.1126637. eCollection 2023.
7
The Influence of SARS-CoV-2 Infection on the Thyroid Gland.
Biomedicines. 2023 Feb 18;11(2):614. doi: 10.3390/biomedicines11020614.
8
Hashimoto's Thyroiditis Encephalopathy Induced by COVID-19 Infection.
Cureus. 2022 Aug 26;14(8):e28419. doi: 10.7759/cureus.28419. eCollection 2022 Aug.
9
The New Entity of Subacute Thyroiditis amid the COVID-19 Pandemic: From Infection to Vaccine.
Diagnostics (Basel). 2022 Apr 12;12(4):960. doi: 10.3390/diagnostics12040960.
10
Subacute thyroiditis associated with COVID-19 infection: a report of an increasing entity.
Arch Endocrinol Metab. 2022 Mar 8;66(1):118-128. doi: 10.20945/2359-3997000000446.
本文引用的文献
1
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries.
Cancer Cytopathol. 2020 Dec;128(12):885-894. doi: 10.1002/cncy.22373. Epub 2020 Oct 27.
2
Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis.
J Endocrinol Invest. 2021 May;44(5):1085-1090. doi: 10.1007/s40618-020-01436-w. Epub 2020 Oct 6.
3
Subacute Thyroiditis Associated with COVID-19.
Case Rep Endocrinol. 2020 Sep 28;2020:8891539. doi: 10.1155/2020/8891539. eCollection 2020.
4
Subacute thyroiditis associated with COVID-19.
BMJ Case Rep. 2020 Aug 25;13(8):e237336. doi: 10.1136/bcr-2020-237336.
5
Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series.
J Clin Endocrinol Metab. 2020 Oct 1;105(10). doi: 10.1210/clinem/dgaa537.
6
Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic.
Hormones (Athens). 2021 Mar;20(1):219-221. doi: 10.1007/s42000-020-00230-w. Epub 2020 Jul 16.
7
Extrapulmonary manifestations of COVID-19.
Nat Med. 2020 Jul;26(7):1017-1032. doi: 10.1038/s41591-020-0968-3. Epub 2020 Jul 10.
8
A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.
Am J Med Sci. 2020 Jul;360(1):5-34. doi: 10.1016/j.amjms.2020.05.006. Epub 2020 May 11.
9
New-Onset Diabetes in Covid-19.
N Engl J Med. 2020 Aug 20;383(8):789-790. doi: 10.1056/NEJMc2018688. Epub 2020 Jun 12.
10
Extrapulmonary and atypical clinical presentations of COVID-19.
J Med Virol. 2020 Nov;92(11):2458-2464. doi: 10.1002/jmv.26157. Epub 2020 Jun 29.
Zotero 插件